�2-Microglobulin and Other Proteins as Parameter for Tubular Function1

M. Weise,D. Pr�fer,G. Jaques,M. Keller,A. W. Mondorf
DOI: https://doi.org/10.1159/000395233
2024-05-18
Contributions to Nephrology
Abstract:Urinary excretion of the low molecular weight protein beta 2-microglobulin and tubular enzymes--alanine aminopeptidase (AAP), gamma-glutamyl transpeptidase (gamma-GT) and alkaline phosphatase (AP)--are very sensitive parameters for proximal tubular lesions. In patients with preeclampsia the renal excretion of beta 2-microglobulin allows to differentiate between a primary preeclampsia and a preeclampsia superimposed upon chronic pyelonephritis. In the first group the increase is 3- to 4-fold and in the second group up to 300-fold. In patients with kidney transplantation the urinary excretion of beta 2-microglobulin, AAP, gamma-GT and AP are several times higher than in normals. In case of a rejection episode a further increase of these proteins occur in more than 80% several days before clinical symptoms are present. The application of analgetics (paracetamol, acetylsalicylic acid) in healthy individuals in therapeutical dosages on 3 consecutive days does not show any tubular alteration by the measurement of urinary beta 2-microglobulin. Aminoglycosides (tobramycin, UK 18,892) lead to a cumulative increase of the renal excretion of beta 2-microglobulin and AAP while cephalosporins induce an increase of total proteins in the final urine under the same conditions.
urology & nephrology
What problem does this paper attempt to address?
The paper attempts to address issues primarily focused on evaluating the effectiveness of β2-microglobulin and other proteins as parameters of tubular function. Specifically, the researchers aim to explore the application of these indicators in the following situations by comparing the urinary excretion of β2-microglobulin and tubular enzymes (such as alanine aminopeptidase, γ-glutamyl transpeptidase, and alkaline phosphatase) under different experimental and clinical conditions: 1. **Hypertensive disorders of pregnancy (preeclampsia)**: Investigate the changes in urinary excretion of β2-microglobulin in patients with preeclampsia to distinguish between primary preeclampsia and preeclampsia secondary to chronic pyelonephritis. 2. **Rejection after kidney transplantation**: Predict the occurrence of rejection by monitoring changes in the urinary excretion of β2-microglobulin and tubular enzymes in kidney transplant patients, thereby providing a basis for early diagnosis. 3. **Potential nephrotoxicity of drugs**: Evaluate the impact of commonly used analgesics (such as acetaminophen and aspirin) and antibiotics (such as cephalosporins and aminoglycoside antibiotics) on tubular function, particularly whether they cause tubular damage. Through these studies, the authors hope to provide clinicians with a more sensitive and specific method for the early detection and assessment of changes in tubular function, thereby improving patient management and treatment outcomes.